The Zhitong Finance App learned that Swiss clinical-stage biotech company Windward Bio Group plans to seek a valuation of up to 1 billion US dollars in an initial public offering (IPO) in the US. The company said on Monday that it plans to issue approximately 10.3 million shares at an issue price range of US$16-18 per share to raise up to US$185.3 million. The company will be listed on NASDAQ under the ticker symbol “WWB.”

The Zhitong Finance App learned that Swiss clinical-stage biotech company Windward Bio Group plans to seek a valuation of up to 1 billion US dollars in an initial public offering (IPO) in the US. The company said on Monday that it plans to issue approximately 10.3 million shares at an issue price range of US$16-18 per share to raise up to US$185.3 million. The company will be listed on NASDAQ under the ticker symbol “WWB.”